Karus makes two R&D appointments
This article was originally published in Scrip
Executive Summary
Karus Therapeutics, which develops medicines for the treatment of inflammatory diseases and cancer, has made two new appointments: Dr Simon Roitt, joins as head of clinical development and Dr Peter Finan, has been appointed head of biology.